204 related articles for article (PubMed ID: 12966600)
1. Determinants of discordance between patients and physicians in their assessment of lupus disease activity.
Yen JC; Abrahamowicz M; Dobkin PL; Clarke AE; Battista RN; Fortin PR
J Rheumatol; 2003 Sep; 30(9):1967-76. PubMed ID: 12966600
[TBL] [Abstract][Full Text] [Related]
2. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
[TBL] [Abstract][Full Text] [Related]
3. Discordant assessment of lupus activity between patients and their physicians: the Singapore experience.
Leong KP; Chong EY; Kong KO; Chan SP; Thong BY; Lian TY; Chng HH; Koh ET; Teh CL; Lau TC; Law WG; Cheng YK; Badsha H; Chew LC; Yong WH; Howe HS;
Lupus; 2010 Jan; 19(1):100-6. PubMed ID: 19880553
[TBL] [Abstract][Full Text] [Related]
4. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.
Wollaston SJ; Farewell VT; Isenberg DA; Gordon C; Merrill JT; Petri MA; Kalunian KC;
J Rheumatol; 2004 Dec; 31(12):2390-4. PubMed ID: 15570639
[TBL] [Abstract][Full Text] [Related]
5. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
[TBL] [Abstract][Full Text] [Related]
6. Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores.
Alarcón GS; McGwin G; Brooks K; Roseman JM; Fessler BJ; Sanchez ML; Bastian HM; Friedman AW; Baethge BA; Reveille JD;
Arthritis Rheum; 2002 Aug; 47(4):408-13. PubMed ID: 12209488
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
8. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?
Jolly M
J Rheumatol; 2005 Sep; 32(9):1706-8. PubMed ID: 16142864
[TBL] [Abstract][Full Text] [Related]
9. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
10. Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity.
Chang ER; Abrahamowicz M; Ferland D; Fortin PR
J Rheumatol; 2002 Nov; 29(11):2350-8. PubMed ID: 12415591
[TBL] [Abstract][Full Text] [Related]
11. Prospective analysis of clinical evaluation and self-assessment by patients after decompression surgery for degenerative lumbar canal stenosis.
Haro H; Maekawa S; Hamada Y
Spine J; 2008; 8(2):380-4. PubMed ID: 17433781
[TBL] [Abstract][Full Text] [Related]
12. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
[TBL] [Abstract][Full Text] [Related]
14. Associates of health status in patients with systemic lupus erythematosus.
Sutcliffe N; Clarke AE; Levinton C; Frost C; Gordon C; Isenberg DA
J Rheumatol; 1999 Nov; 26(11):2352-6. PubMed ID: 10555890
[TBL] [Abstract][Full Text] [Related]
15. The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36.
Colangelo KJ; Pope JE; Peschken C
J Rheumatol; 2009 Oct; 36(10):2231-7. PubMed ID: 19723907
[TBL] [Abstract][Full Text] [Related]
16. Do lupus disease activity measures detect clinically important change?
Fortin PR; Abrahamowicz M; Clarke AE; Neville C; Du Berger R; Fraenkel L; Liang MH
J Rheumatol; 2000 Jun; 27(6):1421-8. PubMed ID: 10852264
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
18. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?
Kanwal F; Hays RD; Kilbourne AM; Dulai GS; Gralnek IM
Am J Gastroenterol; 2004 Sep; 99(9):1726-32. PubMed ID: 15330910
[TBL] [Abstract][Full Text] [Related]
19. Discordance between physician's and parent's global assessments in juvenile idiopathic arthritis.
Sztajnbok F; Coronel-Martinez DL; Diaz-Maldonado A; Novarini C; Pistorio A; Viola S; Ruperto N; Buoncompagni A; Martini A; Ravelli A
Rheumatology (Oxford); 2007 Jan; 46(1):141-5. PubMed ID: 16782733
[TBL] [Abstract][Full Text] [Related]
20. Small changes in outpatients lupus activity are better detected by clinical instruments than by laboratory tests.
Fortin PR; Abrahamowicz M; Danoff D
J Rheumatol; 1995 Nov; 22(11):2078-83. PubMed ID: 8596148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
